MDS clinical diagnostic criteria for Parkinson's disease RB Postuma, D Berg, M Stern, W Poewe, CW Olanow, W Oertel, J Obeso, ... Movement disorders 30 (12), 1591-1601, 2015 | 5950 | 2015 |
MDS research criteria for prodromal Parkinson's disease D Berg, RB Postuma, CH Adler, BR Bloem, P Chan, B Dubois, T Gasser, ... Movement Disorders 30 (12), 1600-1611, 2015 | 1377 | 2015 |
Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up MC Rodriguez-Oroz, JA Obeso, AE Lang, JL Houeto, P Pollak, ... Brain 128 (10), 2240-2249, 2005 | 1315 | 2005 |
Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease Deep-Brain Stimulation for Parkinson's Disease Study Group New England Journal of Medicine 345 (13), 956-963, 2001 | 1298 | 2001 |
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease P Redgrave, M Rodriguez, Y Smith, MC Rodriguez-Oroz, S Lehericy, ... Nature Reviews Neuroscience 11 (11), 760-772, 2010 | 1167 | 2010 |
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms MC Rodriguez-Oroz, M Jahanshahi, P Krack, I Litvan, R Macias, E Bezard, ... The Lancet Neurology 8 (12), 1128-1139, 2009 | 1102 | 2009 |
Pathophysiology of the basal ganglia in Parkinson's disease JA Obeso, MC Rodriguez-Oroz, M Rodriguez, JL Lanciego, J Artieda, ... Trends in neurosciences 23, S8-S19, 2000 | 1081 | 2000 |
Functional neuroanatomy of the basal ganglia JL Lanciego, N Luquin, JA Obeso Cold Spring Harbor perspectives in medicine 2 (12), a009621, 2012 | 1038 | 2012 |
Manual motor performance in a deafferented man JC Rothwell, MM Traub, BL Day, JA Obeso, PK Thomas, CD Marsden Brain 105 (3), 515-542, 1982 | 1021 | 1982 |
Missing pieces in the Parkinson's disease puzzle JA Obeso, MC Rodriguez-Oroz, CG Goetz, C Marin, JH Kordower, ... Nature medicine 16 (6), 653-661, 2010 | 986 | 2010 |
The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease CD Marsden, JA Obeso Brain 117 (4), 877-897, 1994 | 934 | 1994 |
Selective neuronal vulnerability in Parkinson disease DJ Surmeier, JA Obeso, GM Halliday Nature Reviews Neuroscience 18 (2), 101-113, 2017 | 932 | 2017 |
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy JA Obeso, M Stamelou, CG Goetz, W Poewe, AE Lang, D Weintraub, ... Movement disorders 32 (9), 1264-1310, 2017 | 875 | 2017 |
Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease JA Obeso, MC Rodríguez‐Oroz, B Benitez‐Temino, FJ Blesa, J Guridi, ... Movement disorders: official journal of the Movement Disorder Society 23 (S3 …, 2008 | 847 | 2008 |
The anatomical basis of symptomatic hemidystonia CD Marsden, JA Obeso, JJ Zarranz, AE Lang Brain 108 (2), 463-483, 1985 | 720 | 1985 |
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys A Recasens, B Dehay, J Bové, I Carballo‐Carbajal, S Dovero, ... Annals of neurology 75 (3), 351-362, 2014 | 695 | 2014 |
Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications CW Olanow, JA Obeso, F Stocchi The Lancet Neurology 5 (8), 677-687, 2006 | 650 | 2006 |
Chaperone-mediated autophagy markers in Parkinson disease brains L Alvarez-Erviti, MC Rodriguez-Oroz, JM Cooper, C Caballero, I Ferrer, ... Archives of neurology 67 (12), 1464-1472, 2010 | 648 | 2010 |
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease D Berg, RB Postuma, B Bloem, P Chan, B Dubois, T Gasser, CG Goetz, ... Movement Disorders 29 (4), 454-462, 2014 | 598 | 2014 |
Levodopa motor complications in Parkinson's disease JA Obeso, CW Olanow, JG Nutt Trends in neurosciences 23, S2-S7, 2000 | 585 | 2000 |